Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Multicycle highthroughput growth batch Bayesian optimization
3+ hour, 22+ min ago (167+ words) This study evaluates Batch Bayesian Optimization as a robust alternative using Sporosarcina pasteurii to optimize microbial growth media. Click below to begin your download. In silico simulations revealed that BBO outperformed DoE by an average of 14%. This success translated effectively…...
Alternative to Silicone-Based Antifoams in Microbial Fermentation
4+ hour, 42+ min ago (165+ words) This poster presents a cell-free platform enabling rapid assessment of mRNA translational competence using eukaryotic lysates derived from HEK, CHO, K562, and Sf21 cells—without the need for cell-based assays. Click below to begin your download. Efficient development of mRNA therapeutics is…...
A robust system for high-titer, platform-agnostic AAV production
4+ day, 22+ hour ago (98+ words) Cell media serves as a foundational element in these platforms, contributing to both the health and productivity of cells as well as the efficacy of small molecules driving transfection and packaging. Click below to begin your download. Mar 16, 2027 TO Mar…...
Cell Culture MediaFeed Optimization Extends Fed-Batch Performance
5+ day, 26+ min ago (71+ words) Click below to begin your download. Mar 16, 2027 TO Mar 17, 2027 1,000+ biopharma professionals meet in San Diego to explore bioprocessing innovations, connect with industry leaders, and discover cutting-edge technologies for mAbs, vaccines, and cell & gene therapies. Scientist III, OPM Biosciences Europe widens…...
Adriana Kiędzierska-Mencfeld, PhD, CEO of Rezon Bio, presents
1+ week, 6+ day ago (120+ words) the CDMO's challenge to optimize the mAb fragment commercial process without changing the foundation to improve yield, enhance process robustness and avoid major infrastructure changes. Jun 7, 2027 TO Jun 10, 2027 The BIO International Convention is Biotechnology Innovation Organization (BIO) annual event with…...
Interview John Tomtishen, Global Head of Cell Therapy, Catalent
1+ week, 6+ day ago (85+ words) Jun 7, 2027 TO Jun 10, 2027 The BIO International Convention is Biotechnology Innovation Organization (BIO) annual event with over 20,000 industry leaders attending from across the globe. It also hosts the BioProcess International Theater in the BioProcess Zone on the exhibition floor. BPI's mid-year…...
Strategic Operations: Integrated Planning and Gross-to-Net
1+ week, 6+ day ago (135+ words) Brian Barbash, Partner, Pharosity Consulting, an Argano Company, spoke to the BioProcess International Theater audience at BIO June 2026, about their work in strategic operations for market access and finance for life sciences manufacturers. Brian explained the success companies have had…...
Innovations and Trends in Biologics Development
1+ week, 6+ day ago (118+ words) Taking place at BioProcess International Theater at BIO June 2026, Kevin Zen, Senior Director, CMC Technical Operations, Opthea, discusses innovations and trends in biologics development through analytical technologies. Jun 7, 2027 TO Jun 10, 2027 The BIO International Convention is Biotechnology Innovation Organization (BIO) annual…...
Pulse of BioPharma: Industry Today and Trends of Tomorrow
1+ week, 6+ day ago (119+ words) Taking place at BioProcess International Theater at BIO June 2026, Dawn Ecker, Managing Director of bioTRAK Database Services, BDO discusses the state of the industry and trends of tomorrow. Jun 7, 2027 TO Jun 10, 2027 The BIO International Convention is Biotechnology Innovation Organization (BIO)…...
Commercialization of a Stem Cell Therapeutic Drug
1+ week, 6+ day ago (126+ words) Taking place at BioProcess International Theater at BIO June 2026, Lee Smith, Principal Consultant, Director, Greyrigge discusses how a QbD approach assisted with the commercialization of a stem cell therapeutic drug, accelerating the product to market. Jun 7, 2027 TO Jun 10, 2027 The BIO…...